chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

IBRX280121C00001500
IBRX Jan 21 2028 1.50 Call
optionOPRA

InactiveSep 30, 2026
8.25USD+18.364%(+1.28)5Vol38OI
Loading…
Underlying
IBRX
Underlying Price
$8.36
Type
Call
Strike
1.5
Expiration
Jan 21, 2028
DTE
458d
Moneyness
ITM
Intrinsic
$6.86
IBRX 1.5 Call Across Expirations
ExpirationDTELastChangeVolOpen Int
Jan 15, 202787d$8.20+13.89%15412
Jan 21, 2028458d$8.25+18.36%538
IBRX Nearby Strikes · Jan 21, 2028
StrikeLastChangeVolOpen IntMoneyness
.5 C$8.93-4.18%2128ITM
1 C$9.25-2.63%175ITM
1.5 C$8.25+18.36%538ITM
2 C$7.90-10.63%45,401ITM
2.5 C$7.40-7.50%615,793ITM
3 C$6.50-16.13%131,197ITM
3.5 C$7.10+1.87%1027,275ITM
4 C$6.75-1.75%152,170ITM
4.5 C$6.65+2.78%2380ITM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.